FDA Allows At-Home Dosing of Intranasal Foralumab for Multip

The FDA’s decision to allow at-home dosing of intransal foralumab for patients with multiple sclerosis is likely to improve patient compliance to treatment and health outcomes, according to a recent release statement.

Related Keywords

Italy , Milan , Lombardia , Tanuja Chitnis , Gabriele Cerrone , Williama Clementi , Harvard Medical School , Tiziana Life Sciences , Tiziana Life Sciences Announces Allowance By , Tiziana Life Science , Expanded Disability Status Scale , Modified Fatigue Impact Score , Mass General Brigham , Mass General Brigham Healthcare System , Tiziana Life , Published October , Life Sciences ,